146 related articles for article (PubMed ID: 15354092)
1. Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts.
Fujinaga K; Onoda K; Yamamoto K; Imanaka-Yoshida K; Takao M; Shimono T; Shimpo H; Yoshida T; Yada I
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):357-63. PubMed ID: 15354092
[TBL] [Abstract][Full Text] [Related]
2. Locally applied cilostazol suppresses neointimal hyperplasia and medial thickening in a vein graft model.
Yamamoto K; Onoda K; Sawada Y; Fujinaga K; Imanaka-Yoshida K; Yoshida T; Shimpo H
Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):322-30. PubMed ID: 17954989
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis.
Sawada Y; Onoda K; Imanaka-Yoshida K; Maruyama J; Yamamoto K; Yoshida T; Shimpo H
Cardiovasc Res; 2007 Jun; 74(3):366-76. PubMed ID: 17383619
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.
Yamamoto K; Onoda K; Sawada Y; Fujinaga K; Imanaka-Yoshida K; Shimpo H; Yoshida T; Yada I
Cardiovasc Res; 2005 Feb; 65(3):737-42. PubMed ID: 15664401
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
Takigawa T; Tsurushima H; Suzuki K; Tsuruta W; Nakamura K; Matsumura A
J Vasc Surg; 2012 Feb; 55(2):506-16. PubMed ID: 22264805
[TBL] [Abstract][Full Text] [Related]
6. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
Moon MC; Molnar K; Yau L; Zahradka P
J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
[TBL] [Abstract][Full Text] [Related]
7. Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery.
Ishizaka N; Taguchi J; Kimura Y; Ikari Y; Aizawa T; Togo M; Miki K; Kurokawa K; Ohno M
Atherosclerosis; 1999 Jan; 142(1):41-6. PubMed ID: 9920504
[TBL] [Abstract][Full Text] [Related]
8. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
9. Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model.
Malliaris SD; Munabi NCO; Akelina Y; Ascherman JA
Plast Reconstr Surg; 2014 Dec; 134(6):895e-901e. PubMed ID: 25415112
[TBL] [Abstract][Full Text] [Related]
10. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
Hirschberg K; Radovits T; Loganathan S; Entz L; Beller CJ; Gross ML; Sandner P; Karck M; Szabó G
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1508-14. PubMed ID: 19464472
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
Lee KM; Lee HJ; Kim MK; Kim HS; Jung GS; Hur SH; Kim HT; Cho WH; Kim JG; Kim BW; Lim JO; Choi HS; Lee KU; Park KG; Lee IK
Atherosclerosis; 2009 Dec; 207(2):391-8. PubMed ID: 19586629
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol suppresses neointimal hyperplasia in canine vein grafts.
Kudo FA; Kondo Y; Muto A; Miyazaki K; Dardik A; Nishibe M; Nishibe T
Surg Today; 2009; 39(2):128-32. PubMed ID: 19198990
[TBL] [Abstract][Full Text] [Related]
15. [The pilot study of the effect of paclitaxel by local slow delivery on intimal hyperplasia of vascular anastomosis after vascular graft bypass].
Yuan L; Zhang XM; Li YK; Li QL; Zhao KQ; Sun KK; Xie DH; Zhang T
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3056-9. PubMed ID: 18261351
[TBL] [Abstract][Full Text] [Related]
16. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
17. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
18. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation.
Sakaguchi T; Asai T; Belov D; Okada M; Pinsky DJ; Schmidt AM; Naka Y
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):129-37. PubMed ID: 15632834
[TBL] [Abstract][Full Text] [Related]
19. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
